Navigation Links
City of Hope Uses Isilon IQ to Advance Fight Against Life-Threatening Diseases
Date:4/28/2009

World-Renowned Biomedical Research and Treatment Facility Deploys Isilon Scale-out NAS to Power DNA Sequencing Workflow, Accelerating Cancer, Diabetes, and HIV/AIDS Research

SEATTLE, April 28 /PRNewswire-FirstCall/ -- Isilon(R) Systems (Nasdaq: ISLN), the proven leader in scale-out NAS, today announced that City of Hope, a National Cancer Institute-designated Comprehensive Cancer Center, has deployed Isilon IQ to accelerate its next-generation DNA sequencing operations and speed time-to-results for groundbreaking research for cancer, diabetes, and HIV/AIDS. Using Isilon scale-out NAS, City of Hope has unified massive amounts of mission-critical genomic data, streamlining access and analysis to increase workflow productivity while reducing storage management costs.

"Genomic research may very well transform modern medicine by uncovering the genetic precursors for a multitude of life-threatening diseases," said Dr. Richard Jove, director of Beckman Research Institute, City of Hope. "Yet these connections can only be made with the right data, at the right time. With Isilon IQ, we now have the storage infrastructure in place to not only accelerate our DNA sequencing workflow, but also seamlessly expand our capacity to support critical research in the areas of proteomics, chemiformatics and imaging."

City of Hope is one of only 40 National Cancer Institute-designated Comprehensive Cancer Centers in the United States and a founding member of the National Comprehensive Cancer Network. An independent biomedical research, treatment and education institution, its leading-edge research aims to advance the fight against cancer, diabetes, HIV/AIDS and other life-threatening diseases. By combining next-generation technology with the latest genomic, proteomic, chemiformatic and imaging research methodologies, City of Hope discoveries have led to the development of some of today's most notable medical breakthroughs, including the first synthetic human insulin and human growth hormone, as well as the widely used cancer fighting drugs Herceptin, Rituxan and Avastin.

Working with leading Isilon value-added systems integrator Talon Data Systems, City of Hope has deployed Isilon IQ to centralize enormous amounts of mission-critical genomic sequencing data into a single, high-performance, highly scalable shared pool of storage, enabling researchers to directly store and analyze DNA sequencing data without interruption or downtime. Isilon scale-out NAS, featuring its OneFS(R) operating system software, provides City of Hope with an efficient, easy-to-manage storage infrastructure that accelerates productivity while reducing storage management overhead, enabling City of Hope researchers to spend their time on science, not on storage.

"City of Hope has been leading the fight against life-threatening disease for nearly 100 years, enabling some of modern medicine's most significant advances," said Ram Appalaraju, vice president of marketing, Isilon Systems. "By using Isilon IQ to power their groundbreaking research, City of Hope is demonstrating the enormous value our scale-out NAS solutions can deliver for today's leading bioinformatics organizations."

Talon Data Systems is a leading supplier of enterprise-class storage, networking, and Wide Area Network (WAN) solutions. By providing City of Hope with initial workflow analysis and system installation, as well as ongoing support, Talon Data ensured the seamless integration of the Isilon solution with City of Hope's IT infrastructure, accelerating system deployment to maximize results.

"City of Hope's next-generation research necessitates a truly mission-critical storage infrastructure, making non-disruptive system installation and efficient, ongoing operation vital," said Tom Shearer, principal, Talon Data Systems. "By combining Isilon's industry-leading ease-of-use with our expertise in workflow design, service and support, we were able to provide City of Hope with the best storage solution to meet their needs while maintaining the full integrity of their IT environment."

About Isilon Systems

Isilon Systems (NASDAQ: ISLN) is the proven leader in scale-out NAS. Isilon's clustered storage and data management solutions drive unique business value for customers by maximizing the performance of their mission-critical applications, workflows, and processes. Isilon enables enterprises and research organizations worldwide to manage large and rapidly growing amounts of file-based data in a highly scalable, easy-to-manage, and cost-effective way. Information about Isilon can be found at http://www.isilon.com.

The names of companies mentioned herein are the trademarks of their respective owners.


'/>"/>
SOURCE Isilon Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research
2. Isilon Named Best of Show at Bio-IT World 2008
3. HBO, Warner Bros. Employee Initiatives and the Alzheimers Association, California Southland Chapter Present a Free, Public, Advance Screening of THE ALZHEIMERS PROJECT: Caregivers
4. Future for radioembolisation in patients with advanced hepatocellular carcinoma
5. Advancements in Integrative Medicine Research to Be Evaluated by Scientists From Leading International Academic Health Centers
6. Educating referring clinicians about advanced imaging leads to drop in imaging exams
7. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
8. New advances in cancer research to be highlighted at University of Leicester
9. Singapore Adopts Advanced Genetic Engineering in Orthopedic Surgery
10. Millstone Medical Outsourcing Celebrates New Fall River Facility, Designed to Meet Demand for Advanced Inspection, Clean Room Services
11. Circadiance Launches the New SleepWeaver(TM) ADVANCE All Cloth CPAP Mask
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... 2017 partnership with The Jensie Gran Fondo of Marin. For the second year ... with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our safe, ...
(Date:2/23/2017)... ... 23, 2017 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Miami Beach to host its Swirl: Miami Wine Tasting Event on March 28, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael ... “Mama June: From Not to Hot,” which will begin airing on February 24, 2017. ... to millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO ... the National Institute for Health and Care Excellence (NICE) framework. The ... National Health Service (NHS) to search, order and purchase medical and healthcare-related content ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
Breaking Medicine Technology: